Ibnsina Pharma (ISPH) Key Statistics
26 reported figures for Ibnsina Pharma — valuation multiples, the latest fiscal year's income statement, balance-sheet totals, growth rates and technical readings. Figures with no reported value are omitted rather than shown as zero.
Valuation
- Market cap
- EGP 14.5B
- P/E (trailing)
- 15.74
- P/B
- 4.7
- Dividend yield
- 1%
Income (latest fiscal year)
- Revenue
- EGP 76.6B
- Net income
- EGP 771.11M
- EBITDA
- EGP 3.95B
- Free cash flow
- EGP -805.66M
- Profit margin
- 1.01%
Balance sheet
- Total assets
- EGP 36.21B
- Total debt
- EGP 26.67B
- Book value
- EGP 2.78B
Growth
- Revenue growth
- 37.17%
- Profit growth
- 54.9%
- EPS growth
- 54.92%
Per share
- EPS (fiscal year)
- 0.77
- Book value per share
- 2.76
- Dividend per share
- 0.13
- Return on equity
- 32.03%
- Return on assets
- 2.38%
Technical
- RSI (14)
- 50
- 50-day moving average
- EGP 12.53
- 200-day moving average
- EGP 11.57
- Beta (1Y)
- 1.2
Shares
- Shares outstanding
- 1.12B
- Free float
- 65.08%
Source: company disclosures to the Egyptian Exchange via TradingView. Fiscal-year figures are as last reported; technical readings refresh with market data.